Federal Prisons Naloxone Access Act of 2025

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 6789 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 6789 To amend title 18, United States Code, to require the Bureau of Prisons to ensure the availability of opioid antagonists at Federal correctional facilities. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES December 17, 2025 Mrs. Foushee (for herself, Mrs. McBath, and Mr. Johnson of Georgia) introduced the following bill; which was referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend title 18, United States Code, to require the Bureau of Prisons to ensure the availability of opioid antagonists at Federal correctional facilities. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Federal Prisons Naloxone Access Act of 2025''. SEC. 2. AVAILABILITY OF OPIOID ANTAGONISTS. Chapter 303 of title 18, United States Code, is amended-- (1) by adding at the end the following: ``Sec. 4052. Availability of opioid antagonists ``(a) In General.--The Director of the Bureau of Prisons shall ensure that-- ``(1) an adequate number of opioid antagonist kits are maintained at each correctional facility administered by the Bureau, and such kits are available in-- ``(A) medical housing units; ``(B) staff breakrooms; and ``(C) visiting areas, living quarters, recreation spaces, dining halls, housing units, work and program locations, hallways, corridor posts, security checkpoints, any area where incarcerated people congregate, and educational and religious areas; ``(2) that each such opioid antagonist kit is maintained appropriately, including storage-- ``(A) in appropriate conditions at room temperature and out of direct sunlight; and ``(B) in a secure area that is accessible to personn